CoChat

Molecular profiling of tumors of the brainstem by sequencing of CSF-derived circulating tumor DNA

Open access
Pan, Changcun, Diplas, Bill H., Chen, Xin, Wu, Yuliang, Xiao, Xiong, Jiang, Liping, Geng, Yibo, Xu, Cheng, Sun, Yu, Zhang, Peng, Wu, Wenhao, Wang, Yu, Wu, Zhen, Zhang, Junting, Jiao, Yuchen, Yan, Hai, Zhang, Liwei · 2019 · Acta Neuropathologica
Cited by 173

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

Brainstem gliomas are molecularly heterogeneous diseases, many of which are difficult to safely surgically resect and have limited treatment options due to their eloquent location. These constraints pose challenges to biopsy, which limits the use of routine molecular profiling and identification of personalized therapies. Here, we explored the potential of sequencing of circulating tumor DNA (ctDNA) isolated from the cerebrospinal fluid (CSF) of brainstem glioma patients as a less invasive approach for tumor molecular profiling. CSF was obtained from patients either intraoperatively (91.2%, 52/57), from ventricular-peritoneal shunt (3.5%, 2/57), or by lumbar puncture (5.3%, 3/57), all prior to surgical manipulation of the tumor. Deep sequencing of glioma-associated genes was performed on CSF-derived ctDNA and, where available, matched blood and tumor DNA from 57 patients, including nine medullary and 23 diffuse intrinsic pontine gliomas (DIPG). At least one tumor-specific mutation was detected in over 82.5% of CSF ctDNA samples (47/57). In cases with primary tumors harboring at least one mutation, alterations were identified in the CSF ctDNA of 97.3% of cases (36/37). In over 83% (31/37) of cases, all primary tumor alterations were detected in the CSF, and in 91.9% (34/37) of cases, at least half of the alterations were identified. Among ten patients found to have primary tumors negative for mutations, 30% (3/10) had detectable somatic alterations in the CSF. Finally, mutation detection using plasma ctDNA was less sensitive than sequencing the CSF ctDNA (38% vs. 100%, respectively). Our study indicates that deep sequencing of CSF ctDNA is a reliable technique for detecting tumor-specific alterations in brainstem tumors. This approach may offer an alternative approach to stereotactic biopsy for molecular profiling of brainstem tumors.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00401-018-1936-6

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Metadata

Authors
Pan, C., Diplas, B. H., Chen, X., Wu, Y., Xiao, X., Jiang, L., Geng, Y., Xu, C., Sun, Y., Zhang, P., Wu, W., Wang, Y., Wu, Z., Zhang, J., Jiao, Y., Yan, H., & Zhang, L.
Venue
Acta Neuropathologica
Published
2018-11-20
Volume
137
Issue
2
Pages
297-306
ISSN
  • 0001-6322 (ISSN-L)
  • 1432-0533
OpenAlex
W2901252647
Cited by
173
References
7
FWCI
7.36
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Molecular profiling of tumors of the brainstem by sequencing of CSF-derived circulating tumor DNA. https://app.cochat.ai/papers/10.1007/s00401-018-1936-6
The paper
Pan, C., Diplas, B. H., Chen, X., Wu, Y., Xiao, X., Jiang, L., Geng, Y., Xu, C., Sun, Y., Zhang, P., Wu, W., Wang, Y., Wu, Z., Zhang, J., Jiao, Y., Yan, H., & Zhang, L. (2019). Molecular profiling of tumors of the brainstem by sequencing of CSF-derived circulating tumor DNA. Acta Neuropathologica. https://doi.org/10.1007/s00401-018-1936-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.